IMMUNITYBIO, INC. (IBRX) Capital expenditures 2016–2025
IMMUNITYBIO, INC. (IBRX) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$3.8MFY2025 · since FY2016: $6.6M → $3.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $3.8M | -44.2% |
| FY2024 | $6.9M | -77.5% |
| FY2023 | $30.6M | -60.9% |
| FY2022 | $78.2M | +132.9% |
| FY2021 | $33.6M | +1911.0% |
| FY2020 | $1.7M | -61.1% |
| FY2019 | $4.3M | -67.3% |
| FY2018 | $13.1M | -62.4% |
| FY2017 | $34.8M | +430.7% |
| FY2016 | $6.6M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice